Understanding Dyspareunia (painful intercourse, coital pain)? This resource provides information on Dyspareunia diagnosis, clinical documentation, and medical coding for healthcare professionals. Find details on ICD-10 codes related to painful intercourse, including causes, symptoms, and treatment options for Dyspareunia. Learn how to accurately document Dyspareunia in patient charts and ensure proper medical coding for reimbursement. Explore resources for managing and treating painful intercourse for improved patient care.
Also known as
Dyspareunia
Painful sexual intercourse.
Dysuria NOS
Painful urination, not otherwise specified.
Sexual aversion and lack of sexual enjoyment
Conditions related to inhibited sexual desire or pleasure.
Other specified female sexual dysfunction
Female sexual dysfunction not elsewhere classified.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the dyspareunia superficial?
When to use each related code
| Description |
|---|
| Painful sexual intercourse |
| Vaginismus |
| Vulvodynia |
Coding N94.1 (Unspecified dyspareunia) without documenting specific details like depth, timing, or location may lead to claim denials.
Failing to code the underlying cause of dyspareunia, such as endometriosis or vaginismus, impacts accurate severity and reimbursement.
Incorrectly coding superficial dyspareunia (N94.10) as deep dyspareunia (N94.11) based on inadequate documentation causes coding errors.
Q: What are the most effective differential diagnosis strategies for dyspareunia in premenopausal women, considering both organic and psychogenic factors?
A: Differential diagnosis of dyspareunia in premenopausal women requires a thorough approach considering both organic and psychogenic etiologies. Start with a detailed patient history, including the onset, location, nature, and timing of the pain, as well as sexual history, gynecological history (including surgeries and infections), and current medications. A physical exam, including a pelvic exam focusing on vulvar, vaginal, and pelvic floor musculature assessment, is crucial. Consider implementing standardized questionnaires like the Female Sexual Function Index (FSFI) or the Pelvic Pain and Urgency/Frequency (PUF) questionnaire to assess symptom severity and impact. Organically, explore possibilities like vulvovaginal atrophy, infections (e.g., candidiasis, bacterial vaginosis), endometriosis, pelvic inflammatory disease, vestibulodynia, and interstitial cystitis. Psychogenic factors such as anxiety, depression, relationship difficulties, history of sexual trauma, or body image concerns may also contribute to or exacerbate pain. Based on initial findings, further investigations might include laboratory tests (e.g., wet mount, cultures, hormone levels), pelvic ultrasound, or laparoscopy. Explore how multidisciplinary collaboration with mental health professionals, physical therapists specializing in pelvic floor dysfunction, or sex therapists can enhance patient care and address complex cases. Accurate diagnosis requires careful consideration of all contributing factors to personalize treatment strategies.
Q: How can clinicians distinguish between superficial and deep dyspareunia during a pelvic exam and what specific treatment approaches are indicated for each?
A: Distinguishing between superficial and deep dyspareunia is key to effective management. Superficial dyspareunia, often described as pain at entry, can be elicited by gentle pressure on the vulva and introitus during the pelvic exam. Causes may include vulvovaginal atrophy, vestibulodynia, infections, or dermatological conditions. Treatment may involve topical estrogens, lubricants, physical therapy for vaginismus or vulvodynia, or treatment of underlying infections. Deep dyspareunia, characterized by pain with deep penetration, may be reproduced during palpation of the uterosacral ligaments or with uterine movement. This may indicate conditions like endometriosis, pelvic inflammatory disease, adenomyosis, or ovarian cysts. Treatment for deep dyspareunia addresses the underlying pathology and may involve hormonal therapy, surgical intervention, or pelvic floor physical therapy. Learn more about specific diagnostic criteria and treatment protocols for each condition to tailor individualized treatment plans.
Patient presents with complaints consistent with dyspareunia, characterized by recurrent or persistent genital pain associated with sexual intercourse. The patient describes the pain as [sharp, burning, aching, throbbing, or other descriptor] located [superficially at the introitus, deep within the pelvis, or other location]. Onset of pain is [related to initial penetration, deep thrusting, specific positions, or other triggers] and the pain [lasts throughout intercourse, subsides after penetration, or other timing]. The patient reports [frequency and duration of pain episodes]. Associated symptoms include [vaginal dryness, muscle spasms, bleeding, or other relevant symptoms]. The patient's gynecological history includes [menarche, menopause status, gravidity, parity, prior surgeries, sexually transmitted infections, or other relevant history]. Current medications include [list medications]. Physical examination revealed [normal external genitalia, vaginal atrophy, tenderness to palpation, pelvic floor muscle hypertonicity, or other relevant findings]. Differential diagnosis includes vaginismus, vulvodynia, endometriosis, pelvic inflammatory disease, and atrophic vaginitis. Assessment: Dyspareunia, likely [primary or secondary] due to [presumptive etiology based on history and physical examination, e.g., hormonal changes, infection, psychological factors, anatomical abnormalities]. Plan: Initial management includes [patient education regarding pelvic floor relaxation techniques, lubricants, hormonal therapy if indicated, referral to pelvic floor physical therapy, or other appropriate interventions]. Follow-up scheduled in [timeframe] to assess treatment response and consider further diagnostic testing if necessary, such as pelvic ultrasound or laparoscopy. ICD-10 code: H25.9 (Dyspareunia, unspecified).